Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual disease

Fig. 2

NETest levels in GNENs and controls. a NETest measurements were significantly higher in GNENs (23 ± 11; n = 46) compared to controls (7 ± 4, p < 0.0001; n = 63). Mean ± SD. Dotted line: NETest upper limit of normal (20%). b The AUROC for NETest levels in GNENs and controls: The AUROC (red line) for differentiating NENs from controls was 0.94 (95%CI: 0.88 to 0.98, p < 0.0001). A maximum AUC = 1 identifies an ideal (perfect) differentiation between disease and non-disease subjects. The diagonal line (AUC = 0.5) corresponds to chance discrimination. The NETest AUC > 0.9 (red line) indicates that it is an excellent biomarker for GNEN

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us